In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores the data to support the use of tenofovir alafenamide in pregnancy.Listen as she gives her perspectives on:DHHS guideline recommendations for the use of TAF in pregnancyPharmacokinetic data to support adequate TAF concentrations throughout pregnancyAvailable antiretroviral pregnancy registry information on the use of TAF in pregnancyData from the IMPAACT 2010 study to support the use of a TAF-containing regimen in pregnancyPresenter:Milena Murray, PharmD, MSc, BCIDP, AAHIVPAssociate Professor Pharmacy PracticeMidwestern University College of PharmacyDowners Grove CampusHIV/ID Clinical PharmacistNorthwestern Memorial HospitalChicago, Illinois Follow along with the slides at:https://bit.ly/3ofTHLrLink to full program: https://bit.ly/2TXTYWx Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related